View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200 / Bevacizumab 15, Cervical Cancer, Cycle 7+
Protocol-ID: 2251 V1.1 (Mini), PEMB200/BEVA15, Cervical Ca, C7+Indication(s)
- Cervical Cancer; ICD-10 C53.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 03.02.2023